Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges
Catalyst Pharmaceuticals' Firdapse delivers strong growth with a 37% CAGR. Click here to find out why CPRX stock is a Hold.
Stockhead on MSN1h
Dr Boreham’s Crucible: This MSA-tackling biotech strives to be ‘different’
Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.
SHCO ALERT: Soho House & Co. Shareholders are Alerted to Contact BFA Law about its Investigation into the Acquisition Offer Price
New York, New York-- (Newsfile Corp. - March 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Soho House & Co. Inc. (NYSE: SHCO), the board of ...
TFX ALERT: Teleflex Incorporated Investors are Alerted to Contact BFA Law about its Securities Fraud Investigation
New York, New York-- (Newsfile Corp. - March 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Teleflex Incorporated (NYSE: TFX) for potential ...
Comfortable Walking Sandals That Reviewers Wore On Vacation
According to my Fitbit I walked over 110 miles in 8 days with these bad boys on,” wrote a reviewer of one pair on our list. “Nothing but comfort!” ...
PharmiWeb7h
Vaginitis Treatment Drug Market Poised for Growth with Rising Awareness & Increasing Cases
Vaginitis Treatment Drug MarketThe global vaginitis treatment drug market is projected to grow from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, expanding at a CAGR of 4.8%. This growth ...